Lab results are too important to go anywhere else

Beaumont Laboratory

Mumps IgG

Mumps Virus Antibody, IgG, EPIC: LAB6897, SOFT: MUMPS

Specimen Collection Criteria

Collect: One Gold-top SST tube.

Physician Office/Drawsite Specimen Preparation

Let specimen clot 30-60 minutes then immediately centrifuge to separate serum from cells. Refrigerate (2-8°C or 36-46°F) the centrifuged collection tube within two hours of collection. (Minimum Serum: 0.5 mL)

Preparation for Courier Transport

Transport: Centrifuged collection tube, refrigerated (2-8°C or 36-46°F). (Minimum Serum: 0.5 mL)

Rejection Criteria

  • Severely lipemic, icteric, heat inactivated, or hemolyzed specimens.   


Specimen Stability for Testing:

Centrifuged SST Tubes and Microtainers® with Separator Gel
Room Temperature (20-26°C or 68-78.8°F): 8 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Unacceptable

Red-top Tubes and Microtainers® without Separator Gel
Room Temperature (20-25°C or 68-77°F): 8 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Unacceptable

Serum Specimens (Pour-Overs)
Room Temperature (20-26°C or 68-78.8°F): 8 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): 1 year

Specimen Storage in Department Prior to Disposal:

Refrigerated (2-8°C or 36-46°F): 7 days


Royal Oak Special Testing Laboratory.


Tuesday - Saturday.
Results available within 3 business days.

Reference Range

Less than or equal to 8.9 AU/mL: Negative - No significant level of detectable mumps virus antibody.
9.0-10.9 AU/mL: Equivocal - Repeat testing in 10-14 days may be helpful.
Greater than or equal to 11.0 AU/mL: Positive - IgG antibody to mumps virus detected which may indicate a current or previous exposure/immunization to mumps virus. Positive IgG antibody levels in the absence of current clinical symptoms may indicate immunity.

Test Methodology

Chemiluminescent Immunoassay.


IgG is first detectable 7-10 days after the onset of symptoms. Once present IgG levels remain detectable for the lifetime of the patient. Eighty to ninety percent of adults have antibody to mumps virus (1).

Clinical Utility

This assay aids in the diagnosis of a recent infection or immunity due to vaccine or previous exposure.

Clinical Disease

Once transmitted, the mumps virus can produce symptomatic and asymptomatic infections. Typical mumps is an acute, self-limiting disease characterized by bilateral or unilateral parotitis. However, mumps virus infections can sometimes cause meningoencephalitis, orchitis, ovaritis, pancreatits, thyroiditis, or infections of the eye or inner ear (1).


Mumps is endemic throughout the world. Prior to licensing of the live attenuated mumps vaccine, epidemics occurred every 2-5 years with the peak incidence occurring from January through May. In the prevaccine era, more than 50% of cases occurred in the 5-to 9-year group and 90% of disease occurred in children under 14 years of age. Today, more than 50% of mumps cases occur in teenagers and young adults. There is only one serotype of mumps virus (1).

Incubation Period

The incubation period is 16-18 days with a range of 2-4 weeks. Patients are infectious from 9 days prior, to 8 days after, the development of parotitis. Urine from mumps patients should be considered infectious for two weeks after onset of symptoms (1).


Mumps is transmitted by direct contact and through inhalation of infectious aerosols. In addition, the virus can be spread indirectly by autoinoculation of the nose or mouth after handling infected fomites, soiled handkerchiefs, or tissues (1).


  1. Wiedbrauk D, Johnston SLG. Manual of Clinical Virology, Raven Press, New York, NY, 1993.

CPT Code


Test Codes


Last Updated


Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.

This directory currently reflects information only for specimens collected and/or processed at the Farmington Hills, Grosse Pointe, Royal Oak, and Troy campuses.